After receiving Hemgenix gene therapy at Children's Hospital Los Angeles, the 24-year-old is managing hemophilia B with no more infusions—and a newfound freedom.
Facing a new diagnosis? A pediatric oncologist explains what the care journey looks like for acute lymphoblastic leukemia, the most common form of childhood cancer.